Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study - Concepedia

Concepedia

Publication | Closed Access

Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study

244

Citations

20

References

2013

Year

Peter Rich, Bárður Sigurgeirsson, Diamant Thaçi, J.‐P. Ortonne, C. Paul, R. E. Schopf, Akimichi Morita, K. Roseau, Evita Harfst, Achim Guettner,

British Journal of Dermatology

Abstract

Secukinumab shows efficacy for induction and maintenance treatment of moderate-to-severe plaque psoriasis.

References

	Year	Citations

Page 1